| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Depression > Do Children And Adolescents Get Depressed? |
|
E-Articles - Do Children And Adolescents Get Depressed?
Unfortunately, the answer is yes. Depression is much more common in children and adolescents tha According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product n once believed. For reasons that are not well understood, there has been a trend toward an earl ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in er age at onset of depression (and manic-depression) in people born since the 1940’s. Also, clin lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. icians are doing a better job of looking for and recognizing depression in these age groups. Qui here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e often, depression in young people consists of the same symptoms as found in adults. At times, d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro however, the diagnoses may be more elusive. The youngsters may not recognize the discomfort that ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc they are experiencing is an illness known as depression. Although young children may not be able easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi to express their sad mood in words, they often show it with persistent sad expressions. Other i nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically dications of depression in young people are loss of motivation and enthusiasm, fatigue, difficult and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ y making decisions, social withdrawal, weight change (up or down), irritability and anger, deteri ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ration of school performance, truancy, acting out and behavioral difficulties, and physical compl ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ints. Families or teachers may recognize behavioral changes indicative of depression even though dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod the youngster may deny being depressed. Whenever depression is suspected, the child should be e cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin aluated by a doctor experienced in working with this age group. Just as in adults, depression in tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen young people can have a number of causes, and recognizing these causes can lead to very effectiv t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel treatments. Recognizing and treating depression in youngsters is especially important consideri ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ng the critical stages of development they are passing through. Also, there has been a disturbin y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products increase in suicide in adolescents over the last few decades, and although suicide is quite rare . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de in children, it does occur. Treatment for childhood and adolescent depression are the same as t elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ose used in adults and include psychotherapies, medications, and combinations of both. By M Adle tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Benefits of Zipping and Sending Zip Archives Online
|